Parent Navigator Program to help Latino/x families of babies with congenital heart disease connect to developmental services
Official title: Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents
Run by Children's Hospital Los Angeles · NCT07023367 · Data updated 2026-11-12
This trial will test whether a Parent Navigator Program helps Latino/x parents of newborns with congenital heart disease connect to follow-up and early intervention services, improve child neurodevelopment, and reduce parental stress.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 0 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Children's Hospital Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | September 12, 2025 |
| Trial ID | NCT07023367 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Latino/x infants born with congenital heart disease who required medical or surgical intervention within 30 days of life and their parents who are fluent in English or Spanish and not facing major genetic syndromes, major brain lesions, or end-of-life care.
✕Probably not a fit
Patients unlikely to benefit include those with major genetic syndromes, significant brain injuries, infants in end-of-life care, non-Latino/x families, or parents not fluent in English or Spanish.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized interventional trial at Children's Hospital Los Angeles compares a Parent Navigator Program (PNP) to standard care for Latino/x infants with congenital heart disease and their parents. Enrolled infants must have required medical or surgical intervention within 30 days of birth, and families must identify as Latino/x with parents fluent in English or Spanish. The main outcomes measured at six months after randomization are connection to High-Risk Infant Follow-Up (HRIF)/Early Intervention (EI), neurodevelopmental outcomes in the child, and parental stress. Participants with major genetic syndromes, major brain lesions, or receiving end-of-life care are excluded.
Why it matters
Potential benefit: If successful, the program could increase timely enrollment in HRIF/EI, improve early neurodevelopmental outcomes, and reduce parental stress for Latino/x families of infants with CHD.
How similar studies have gone: Previous care-navigation and community health worker programs have improved linkage to early intervention in other pediatric populations, but randomized data specifically in Latino/x infants with CHD are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Latino/x Infants: Inclusion Criteria: * Infants born with CHD requiring medical/surgical intervention at less than 30 days of age * Identify as Latino/x Exclusion Criteria: * Presence of a major genetic syndrome * Intraventricular hemorrhage or other major structural brain lesion * Undergoing end of life care Parents of Latino/x Infants: Inclusion Criteria: * Identify as Latino/x Exclusion Criteria: * Not fluent in English or Spanish
Where it's running
-
Children's Hospital Los Angeles
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Nhu Tran, PhD, RN — Children's Hospital Los Angeles
- Study coordinator: Emma Salmon, BS
- Email: esalmon@chla.usc.edu
- Phone: 323-361-5103
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Prehabilitation before heart surgery for adults with congenital heart disease
This study is testing whether a tailored, supervised exercise program before heart surgery helps adults with congenital heart disease perform better and improve fitness.
-
Accessible care model comparing nurse-led versus physician-led transition education for teens and young adults with congenital heart disease
This project will test whether an accessible care model and nurse-led versus physician-led transition education helps teens and young adults (ages 12–26) with congenital heart disease move successfully from pediatric to adult heart care.
-
Surgical techniques and outcomes across the lifespan in congenital heart disease in China
See which surgical factors and care patterns affect recovery after heart surgery for people with complex congenital heart disease in China.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.